Dr. Mikhail Kogan: Pharmaceutical vs Botanical Cannabinoids - Part 4

In Part 4 of this captivating series, host Chad Taylor and Dr. Mikhail Kogan explore the growing influence of Big Pharma in the cannabis industry and the future of full-spectrum botanical products versus pharmaceutical cannabinoids. Dive deep into the complexities of rescheduling vs. descheduling cannabis and the potential risks of isolating cannabinoids into synthetic forms.

Dr. Kogan shares real-life patient success stories, like the groundbreaking use of cannabinoid creams for skin conditions such as psoriasis and eczema, offering affordable and effective alternatives to expensive pharmaceutical options. Discover why full-spectrum cannabis products harness nature’s synergy and outperform synthetic alternatives, emphasizing the plant’s complexity and its co-evolution with humanity.

This episode also highlights the importance of accessible research, the snowball effect of federal funding for cannabis studies, and the potential to revolutionize healthcare. If you’re curious about cannabis’ role in modern medicine and the battle between natural and synthetic solutions, this is a must-watch!

*The content of this video is for informational and educational purposes only. It is not intended as medical advice, diagnosis, or treatment. Viewers should consult with a qualified healthcare provider for personalized medical advice. The views expressed are those of the speaker and do not necessarily reflect the views of The Doc App, Inc. or its sponsors. No products are promoted or endorsed in this video.*

👉 Like, comment, and subscribe for more episodes uncovering the truth about cannabis and its impact on healthcare!

www.myfloridagreen.com Patient Access to Medical Marijuana

[e-mail]

833-665-3279 (MMJ EASY)